InspireMD Reports Q1 2026 Earnings: Revenue Growth and Operational Challenges

InspireMD reported first-quarter revenue growth driven by its U.S. launch of CGuard Prime, but faced operational challenges including a net loss expansion to $13.7 million due to increased expenses and an inventory impairment charge.

By Motley Fool Transcribing · Motley Fool ·

InspireMD Reports Q1 2026 Earnings: Revenue Growth and Operational Challenges

Tickers: $NSPR

Topics: product_launch regulatory_pause revenue_growth

Read the full article at Motley Fool

More World news